The Kidney Disease: Improving Global Outcomes (KDIGO) 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) serves to update the 2002 KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification following a decade of focused research and clinical practice in CKD.

KDOQI us commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD guidelines of 2012 KDOQI 22 and Diabetic Kidney Disease (KDIGO) Clinical Practice Guideline for Anemia The 2012 KDIGO (Kidney Disease: Improving Global Outcomes) Clinical Practice Guideline for Anemia in Chronic Kidney Disease provides clinicians with comprehensive evidence-based recommendations to improve patient care. In this commentary, we review these recommendations and the underlying evidence. Most recommendations are well reasoned. Chronic Kidney Disease (CKD) Assessment and Diagnosis. The National Kidney Foundation (NKF), the American Society for Clinical Pathology (ASCP), the nation's leading laboratories and clinical laboratory societies are collaborating to remove barriers to testing for chronic kidney disease (CKD). The 2012 update of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guideline for Diabetes and Chronic Kidney Disease (CKD) is intended to assist the practitioner caring for patients with diabetes and CKD. Substantial high-quality new evidence has emerged since the original 2007 KDOQI guideline National Kidney Foundatio. n. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 39:S1-S266, 2002 (suppl 1) KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Guidelines are included in the MDwise Provider Manual and posted on the MDwise Web site. In response to the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) guideline for blood pressure management in patients with chronic kidne